Live Breaking News & Updates on Apollon Jamaica Research Development

Stay updated with breaking news from Apollon jamaica research development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill Prostate Cancer Cells

Apollon Formularies Plc (AQSE: APOL) ( Apollon
or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange. ....

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Apollon Formulations Kill Prostate Cancer Cells

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Apollon Formulations Kill Prostate Cancer Cells
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Combined Formulations Kill Breast Cancer Cells

Breast Cancer Cells Through Multiple Pathways

LONDON/TORONTO, Apollon Formularies plc (AQSE: APOL, Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION, Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms: direct cell cytotoxicity, immune stimulated T-cell cytotoxicity, and macrophage induced phagocytosis. HER2-positive constitutes approximately 20% of all breast cancers.

The testing was performed by BIOENSIS, an independent, pre-clinical predictive pharmaceutical testing laboratory. The medical cannabis formulations were developed by Apollon s affiliate, Apollon Formularies Jamaica Limited ( Apollon Jamaica ), and the medic ....

United States , United Kingdom , City Of , Herberta Fritsche , Graham Simmonds , Trastuzumab Herceptin , Stephend Barnhill , Megan Ray , Paul Burke , Tim Blythe , Stene Jacobs , Aion Therapeutic Inc , Apollon Formularies Jamaica , Doc Place International Inc , Md Anderson Cancer Center , Research Development , Trefis Team , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Decision Resources Group , Ai Pharmaceutical Limited Pharma , Canadian Securities Exchange , Handbook Of Cannabis Oxford University , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority ,

Combined Apollon and Aion Formulations Kill Breast Cancer Cells [...] | Comunicati stampa CataniaOggi

18 maggio 2021 17:32
Fonte: Adnkronos
#salute-e-benessere
LONDON and TORONTO, May 18, 2021 /PRNewswire/ Apollon Formularies plc (AQSE: APOL) ( Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) ( Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms: direct cell cytotoxicity, immune stimulated T-cell cytotoxicity, and macrophage induced phagocytosis. HER2-positive constitutes approximately 20% of all breast cancers.
The testing was performed by BIOENSIS, an independent, pre-clinical predictive pharmaceutical testing laboratory. The medical cannabis formulations were developed by Apollon s affiliate, Apollon Formularies Jamai ....

United States , United Kingdom , City Of , Herberta Fritsche , Graham Simmonds , Trastuzumab Herceptin , Stephend Barnhill , Paul Burke , Megan Ray , Tim Blythe , Stene Jacobs , Ai Pharmaceuticals Jamaica Limited Pharma , Aion Therapeutic Inc , Apollon Formularies Jamaica , Doc Place International Inc , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Decision Resources Group , Canadian Securities Exchange , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Peterhouse Capital Limited Corporate Adviser ,

Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways

Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , City Of , Herberta Fritsche , Graham Simmonds , Trastuzumab Herceptin , Rachelm Webster , Stephend Barnhill , Paul Wilcock , Kostenloser Wertpapierhandel , Paul Burke , Megan Ray , Tim Blythe , Stene Jacobs , Ai Pharmaceuticals Jamaica Limited Pharma , Aion Therapeutic Inc , Apollon Formularies Jamaica , Doc Place International Inc , Md Anderson Cancer Center , Research Development , Trefis Team , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Decision Resources Group , Canadian Securities Exchange ,